Interruptions to the inspection programme of the European Directorate for the Quality of Medicines & HealthCare (EDQM) due to travel restrictions (necessary by the COVID-19 pandemic) led to the creation of a system of Real-Time Remote Inspections (RTEMIS). The pilot project combines a live video feed, linking inspectors and manufacturing sites of active pharmaceutical ingredients (APIs), and the review of documentary sources. The objective is to monitor compliance with both Good Manufacturing Practice (GMP) and applications for certificates of suitability for European Pharmacopoeia (CEP) monographs at production sites. July 8, 2021